A compound of the formula (I): R
1
—NH—X—Y-Z (I) wherein each symbol is as defined in the specification, or a pharmaceutically acceptable salt thereof useful as a vascular adhesion protein-1 (VAP-1) inhibitor, a pharmaceutical composition, a method for preventing or treating a VAP-1 associated disease, especially macular edema, which method includes administering an effective amount of the compound or a pharmaceutically acceptable salt thereof to a mammal, and the like.
公式(I)的化合物:R1—NH—X—Y-Z(I),其中每个符号如规范所定义,或其药学上可接受的盐,可用作血管黏附蛋白-1(VAP-1)
抑制剂,制药组合物,预防或治疗VAP-1相关疾病,特别是黄斑
水肿的方法,包括向哺乳动物投与化合物或其药学上可接受的盐的有效量等。